227 related articles for article (PubMed ID: 36846368)
1. Site-directed late-stage diversification of macrocyclic nannocystins facilitating anticancer SAR and mode of action studies.
Zhang H; Tian Y; Yuan X; Xie F; Yu S; Cai J; Sun B; Shan C; Zhang W
RSC Med Chem; 2023 Feb; 14(2):299-312. PubMed ID: 36846368
[TBL] [Abstract][Full Text] [Related]
2. From Target-Oriented to Motif-Oriented: A Case Study on Nannocystin Total Synthesis.
Zhang W
Molecules; 2020 Nov; 25(22):. PubMed ID: 33203102
[TBL] [Abstract][Full Text] [Related]
3. Total Syntheses of Nannocystins A and A0, Two Elongation Factor 1 Inhibitors.
Huang J; Wang Z
Org Lett; 2016 Sep; 18(18):4702-5. PubMed ID: 27598405
[TBL] [Abstract][Full Text] [Related]
4. Novel nannocystin A analogues as anticancer therapeutics: Synthesis, biological evaluations and structure-activity relationship studies.
Liu Q; Yang X; Ji J; Zhang SL; He Y
Eur J Med Chem; 2019 May; 170():99-111. PubMed ID: 30878835
[TBL] [Abstract][Full Text] [Related]
5. Concise Total Synthesis of Nannocystin A.
Liao L; Zhou J; Xu Z; Ye T
Angew Chem Int Ed Engl; 2016 Oct; 55(42):13263-13266. PubMed ID: 27633484
[TBL] [Abstract][Full Text] [Related]
6. A "Motif-Oriented" Total Synthesis of Nannocystin Ax. Preparation and Biological Assessment of Analogues.
Meng Z; Souillart L; Monks B; Huwyler N; Herrmann J; Müller R; Fürstner A
J Org Chem; 2018 Jul; 83(13):6977-6994. PubMed ID: 29265814
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of nannocystin analogues toward understanding the binding role of the (2R,3S)-Epoxide in nannocystin A.
Tian Y; Xu X; Ding Y; Hao X; Bai Y; Tang Y; Zhang X; Li Q; Yang Z; Zhang W; Chen Y
Eur J Med Chem; 2018 Apr; 150():626-632. PubMed ID: 29554614
[TBL] [Abstract][Full Text] [Related]
8. Total Synthesis of Nannocystin A.
Yang Z; Xu X; Yang CH; Tian Y; Chen X; Lian L; Pan W; Su X; Zhang W; Chen Y
Org Lett; 2016 Nov; 18(21):5768-5770. PubMed ID: 27736074
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, and biological activity of m-tyrosine-based 16- and 17-membered macrocyclic inhibitors of hepatitis C virus NS3 serine protease.
Chen KX; Njoroge FG; Pichardo J; Prongay A; Butkiewicz N; Yao N; Madison V; Girijavallabhan V
J Med Chem; 2005 Oct; 48(20):6229-35. PubMed ID: 16190750
[TBL] [Abstract][Full Text] [Related]
10. Pharmacophore mapping in the laulimalide series: total synthesis of a vinylogue for a late-stage metathesis diversification strategy.
Wender PA; Hilinski MK; Skaanderup PR; Soldermann NG; Mooberry SL
Org Lett; 2006 Aug; 8(18):4105-8. PubMed ID: 16928085
[TBL] [Abstract][Full Text] [Related]
11. Macrocyclization of linear molecules by deep learning to facilitate macrocyclic drug candidates discovery.
Diao Y; Liu D; Ge H; Zhang R; Jiang K; Bao R; Zhu X; Bi H; Liao W; Chen Z; Zhang K; Wang R; Zhu L; Zhao Z; Hu Q; Li H
Nat Commun; 2023 Jul; 14(1):4552. PubMed ID: 37507402
[TBL] [Abstract][Full Text] [Related]
12. Discovery, Structure Elucidation, and Biological Characterization of Nannocystin A, a Macrocyclic Myxobacterial Metabolite with Potent Antiproliferative Properties.
Hoffmann H; Kogler H; Heyse W; Matter H; Caspers M; Schummer D; Klemke-Jahn C; Bauer A; Penarier G; Debussche L; Brönstrup M
Angew Chem Int Ed Engl; 2015 Aug; 54(35):10145-8. PubMed ID: 26031409
[TBL] [Abstract][Full Text] [Related]
13. Rhodium(III)-Catalyzed C-H/O
Song B; Guo X; Yang L; Yu H; Zong X; Liu X; Wang H; Xu Z; Lin Z; Yang W
Angew Chem Int Ed Engl; 2023 Apr; 62(15):e202218886. PubMed ID: 36788706
[TBL] [Abstract][Full Text] [Related]
14. Lead Diversification through a Prins-Driven Macrocyclization Strategy: Application to C13-Diversified Bryostatin Analogues.
Wender PA; Billingsley KL
Synthesis (Stuttg); 2013; 45(13):1815-1824. PubMed ID: 24672140
[TBL] [Abstract][Full Text] [Related]
15. Probing the Anticancer Action of Oridonin with Fluorescent Analogues: Visualizing Subcellular Localization to Mitochondria.
Xu S; Luo S; Yao H; Cai H; Miao X; Wu F; Yang DH; Wu X; Xie W; Yao H; Chen ZS; Xu J
J Med Chem; 2016 May; 59(10):5022-34. PubMed ID: 27089099
[TBL] [Abstract][Full Text] [Related]
16. Harnessing C-H Activation of Benzhydroxamates as a Macrocyclization Strategy: Synthesis of Structurally Diverse Macrocyclic Isoquinolones.
Krieger JP; Ricci G; Lesuisse D; Meyer C; Cossy J
Chemistry; 2016 Sep; 22(38):13469-73. PubMed ID: 27219876
[TBL] [Abstract][Full Text] [Related]
17. Recent developments of C-4 substituted coumarin derivatives as anticancer agents.
Dandriyal J; Singla R; Kumar M; Jaitak V
Eur J Med Chem; 2016 Aug; 119():141-68. PubMed ID: 27155469
[TBL] [Abstract][Full Text] [Related]
18. Macrocyclization of organo-peptide hybrids through a dual bio-orthogonal ligation: insights from structure-reactivity studies.
Frost JR; Vitali F; Jacob NT; Brown MD; Fasan R
Chembiochem; 2013 Jan; 14(1):147-60. PubMed ID: 23203912
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of complex head-to-side-chain cyclodepsipeptides.
Pelay-Gimeno M; Albericio F; Tulla-Puche J
Nat Protoc; 2016 Oct; 11(10):1924-1947. PubMed ID: 27658010
[TBL] [Abstract][Full Text] [Related]
20. Cephalostatin analogues--synthesis and biological activity.
Flessner T; Jautelat R; Scholz U; Winterfeldt E
Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
